İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2003 · article

Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet s syndrome

YÖKSİS OpenAlex Üst %10
Yıl2003
Atıf97OpenAlex
Atıf102Semantic Scholar · 8 etkili
Yüzdelik%93,5
FWCI4,221,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q4

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıInternational Journal of Dermatology
  • Katalog eşleşmesi (ISSN)International Journal of Dermatology
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

BACKGROUND/AIMS: Vascular endothelial growth factor (VEGF) is a cytokine participating in inflammation with potent endothelial cell effects. It is produced by macrophages, neutrophils and vascular endothelial cells and can alter vessel permeability. Behçet's syndrome is a systemic inflammatory disorder with unknown etiology. Vascular endothelial dysfunction is one of the prominent features of the disease. We previously demonstrated the possible involvement of proinflammatory cytokines [tumor necrosis factor (TNF)-alpha, soluble interleukin-2 receptor (sIL-2R), interleukin (IL)-6 and IL-8], nitric oxide (NO) and adrenomedullin in the etiopathogenesis of Behçet's syndrome. Since VEGF expression is induced by these cytokines and VEGF itself is a potent stimulator of NO production with endothelial cell effects, this study aimed to investigate whether VEGF was affected during the course of Behçet's syndrome. We also assessed the possible involvement of VEGF in ocular Behçet's syndrome or in disease activity. METHODS: This multicenter case-control study included a total of 39 patients with active (n = 22) or inactive (n = 17) Behçet's syndrome (mean age, 38.1 +/- 10.4 years; 21 men and 18 women) satisfying International Study Group criteria, and 15 healthy hospital-based control volunteers (mean age, 39.2 +/- 9.3 years; eight men and seven women) matched for age and gender from a similar ethnic background. Patients were examined by a dermatologist and an ophthalmologist with an interest in Behçet's syndrome. Plasma VEGF concentrations were measured using a newly established enzyme-linked immunosorbent assay. Clinical findings and acute-phase reactant parameters such as erythrocyte sedimentation rate, alpha1-antitrypsin, alpha2-macroglobulin, and neutrophil count were used to classify the disease in Behçet's patients as active or inactive. The Wilcoxon test or the Mann-Whitney U-test was used for statistical analysis as indicated and the results were expressed as mean +/- SD, with range. RESULTS: The mean plasma VEGF level in patients with Behçet's syndrome (291.9 +/- 97.1 pg/mL; range 121-532 pg/mL) was higher than that in control subjects (103.0 +/- 43.6 pg/mL; range 25-187 pg/mL) and the difference was significant (P < 0.001). Patients with active disease had significantly (P < 0.001) higher VEGF levels than patients with inactive disease (347.6 +/- 87.1 vs. 219.9 +/- 51.6 pg/mL). In addition, ocular Behçet's patients (n = 23) had higher VEGF levels (315.7 +/- 92.1 pg/mL) than nonocular patients (n = 16, 257.8 +/- 96.6 pg/mL) and the difference was of borderline significance (P = 0.041). The levels of all acute-phase reactant parameters were significantly higher in the active stage than in the inactive stage (for each, P < 0.01) or in control subjects (for each, P < 0.001). CONCLUSIONS: VEGF may participate in the course of Behçet's syndrome, especially in the active stage, and elevated levels of VEGF may be an additional risk factor for the development of ocular disease, contributing to poor visual outcome.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

97atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 62 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2014 Management of Behcet’s syndrome 2014Atıf 85 · OpenAlex
  2. 2018 Elevated Monocyte to High-Density Lipoprotein Cholesterol Ratio and Endothelial Dysfunction in Behçet DiseaseAtıf 76 · OpenAlex
  3. 2017 Elevated Monocyte to High-Density Lipoprotein Cholesterol Ratio and Endothelial Dysfunction in Behçet DiseaseAtıf 76 · OpenAlex
  4. 2017 Elevated Monocyte to High-Density Lipoprotein Cholesterol Ratio and Endothelial Dysfunction in Behçet DiseaseAtıf 76 · OpenAlex
  5. 2006 Characterization of the Divergent Wound-Healing Responses Occurring in the Pathergy Reaction and Normal Healthy VolunteersAtıf 72 · OpenAlex
  6. 2012 Results of Interferon Alpha-2a Therapy in Patients with Behcet's DiseaseAtıf 39 · OpenAlex
  7. 2012 Results of Interferon Alpha 2a Therapy in Patients with Behcet s DiseaseAtıf 39 · OpenAlex
  8. 2008 Vascular endothelial growth factor and carotid intima media thickness in patients with Behçet s diseaseAtıf 36 · OpenAlex
  9. 2008 Vascular endothelial growth factor and carotid intima-media thickness in patients with Behcet’xxs diseaseAtıf 36 · OpenAlex
  10. 2008 Vascular endothelial growth factor and carotid intima media thickness in patients with Behçet s diseaseAtıf 36 · OpenAlex

Yazarlar

7
  1. MUSTAFA BAKİ ÇEKMEN 1
  2. CEM EVEREKLİOĞLU 2
  3. H ER 3
  4. HÜSEYİN SERHAT İNALÖZ GAZİANTEP ÜNİVERSİTESİ 4
  5. S DOĞANAY 5
  6. YUSUF TÜRKÖZ 6
  7. İBRAHİM HALİL ÖZEROL 7